ai to select which cells to use for preciously expensive and effective immunotherapy: meet @cellvoyant https://t.co/7SkTFo9QsX
every industry has its high‑stakes systems: software that cannot fail because the cost of failure is borne by real people. in clinical research, that system is the infrastructure that manages participant journeys through clinical trials. these trials are the gateway...
new on @airstreetpress: can ai generate new science? link below https://t.co/5egWvv3OPd
i'm looking for someone who has experience building evals for frontier ai systems for an amazing opportunity at a well-funded @airstreet company with strong traction ideally in london or wanting to move there ping here or dm if you're interested /...
the thesis here btw is simple: - contact center agents today behave like robots, the experience really sucks for the caller and agents get the unfair critique, leading to immense churn - AI will do a far better job of being...
in jan ‘25, uk pm starmer pledged to mainline ai into the veins of the uk with the ai opportunities action plan not only has gov been very slow to deliver on much of it it seems the pm has missed...
two new essays on @airstreetpress next week: 1) tues: can ai generate new science? on ai agents for discovery 3) thurs: rebuilding high-stakes software ai-first - a case study in clinical trials sign up at press(dot)airstreet(dot)com
from the desert to the arctic, @delian_ai detects and takes down aerial threats
what a silly oped on so many levels “But the resource-intensive AI platform bubble in which the US dominates cannot last. A market correction will shift attention to alternative models. This will in turn create new opportunities for Europe, which has...
more capabilities from @delian_ai are coming live this time, from our uk team working for @nato in supplying autonomous navigation to drones in gps-denied environments

embodied ai is clearly undergoing a renaissance driven by progress in foundation models in this essay, i dive into substantive progress in the last 12 months, anchoring on @stateofaireport, with case studies from @SereactAI @wayve_ai @nvidia @allen_ai https://t.co/qHsMlJckuu
🌲 @delian_ai protecting vast territories from wildfires

NVIDIA is partnering with Air Street Capital on a new £2B commitment to invest in and support UK-based AI startups, providing capital, compute and technical expertise to accelerate the UK AI ecosystem. The partnership aims to scale AI infrastructure and...

Isomorphic Labs announced a $600M fundraising round, per coverage in the RAAIS 2025 speaker roundup. The raise was noted alongside the company’s continued push in AI‑first drug development.

Odyssey has raised a Series A round led by EQT Ventures with participation from Air Street and GV, announced in Nathan Benaich & Alex Chalmers' December 1, 2024 newsletter. The company secured Series A financing to support its next stage...